Aptevo Therapeutics (APVO) Shares Outstanding (Diluted) (2016 - 2026)
Aptevo Therapeutics (APVO) recorded Shares Outstanding (Diluted) of 1.2 million in Q2 2026, compared with 41,012 a year earlier and up 12.8% from the prior quarter.
Powered by 
Analysis
Aptevo Therapeutics (APVO) Shares Outstanding (Diluted) (2016 - 2026) Analysis & Trends
For FY2025, Aptevo Therapeutics reported Shares Outstanding (Diluted) of 315,535.
- Annual Shares Outstanding (Diluted) has a five-year compound annual growth rate of 910.1% (FY2020 to FY2025).
- Across earlier years, Shares Outstanding (Diluted) came in at 767.00 in FY2024, 21.00 in FY2023 (+133.3%), 9.00 in FY2022 (+12.5%) and 8.00 in FY2021 (+166.7%).
- The Q2 2026 figure is the highest quarterly Shares Outstanding (Diluted) in data going back to Q3 2016.
- Over the past five years, the year-over-year growth in Shares Outstanding (Diluted) ranged from 12.5% (Q2 2022) to 333.3% (Q1 2024).
- Per Business Quant, the preceding three quarters came in at 1.06 million (Q1 2026), 315,535 (Q4 2025) and 224,965 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Aptevo Therapeutics | 2.58 Mn | -64.42 Mn | - | 1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.06 Mn |
| Dec 31, 2025 | 315,535.00 |
| Sep 30, 2025 | 224,965.00 |
| Jun 30, 2025 | 41,012.00 |
| Mar 31, 2025 | 4,052.00 |
| Dec 31, 2024 | 767.00 |
| Sep 30, 2024 | 792.00 |
| Jun 30, 2024 | 264.00 |
| Mar 31, 2024 | 52.00 |
| Dec 31, 2023 | 21.00 |
| Sep 30, 2023 | 21.00 |
| Jun 30, 2023 | 11.00 |
| Mar 31, 2023 | 12.00 |
| Dec 31, 2022 | 9.00 |
| Sep 30, 2022 | 9.00 |
| Jun 30, 2022 | 9.00 |
| Mar 31, 2022 | 8.00 |
| Dec 31, 2021 | 8.00 |
| Sep 30, 2021 | 8.00 |
API Access
Aptevo Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=APVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "APVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=APVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();